| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |